The analysis showed that PRKDC possessed the highest mutation frequency in the eHCC group compared with the aHCC group, which also significantly associated with poor OS in HCC patients (HR = 1.79, 95% CI: 1.26–2.53). This evidence concerns the gene PRKDC and hepatocellular carcinoma.